The Scientist : A pathway to therapeutic destruction [15/8/2001]

Email: Tudor Toma - t.toma@ic.ac.uk
News from The Scientist 2001, 2(1):20010815-02

15 August 2001

Pancreatic cancers contain defective apoptotic pathways, making the tumour cells resistant to current chemotherapy regimes. But, in August Gut Detjen and colleagues from the Humboldt University, Berlin show that there is still an intact proapoptotic pathway in pancreatic cancer cells activated by interferon γ (IFN-γ) and/or procaspase-1 which may have therapeutic potential.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today